DIMENSIONAL FUND ADVISORS LP - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 85 filers reported holding UTAH MED PRODS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$13,753,473
-4.9%
159,916
+3.1%
0.01%0.0%
Q2 2023$14,457,724
-1.3%
155,127
+0.4%
0.01%0.0%
Q1 2023$14,646,118
+94899.8%
154,538
+0.8%
0.01%0.0%
Q4 2022$15,417
-99.9%
153,368
+0.3%
0.01%0.0%
Q3 2022$13,046,000
-0.7%
152,923
-0.0%
0.01%0.0%
Q2 2022$13,138,000
-2.3%
152,952
+2.2%
0.01%
+25.0%
Q1 2022$13,451,000
-10.4%
149,693
-0.3%
0.00%
-20.0%
Q4 2021$15,010,000
+6.7%
150,101
-0.9%
0.01%0.0%
Q3 2021$14,066,000
+8.7%
151,501
-0.5%
0.01%
+25.0%
Q2 2021$12,943,000
-2.5%
152,190
-0.7%
0.00%0.0%
Q1 2021$13,276,000
-2.7%
153,301
-5.3%
0.00%
-20.0%
Q4 2020$13,640,000
+2.7%
161,806
-2.7%
0.01%
-16.7%
Q3 2020$13,286,000
-11.6%
166,339
-1.9%
0.01%
-14.3%
Q2 2020$15,028,000
-6.2%
169,570
-0.5%
0.01%
-12.5%
Q1 2020$16,020,000
-13.1%
170,355
-0.3%
0.01%
+14.3%
Q4 2019$18,439,000
+11.6%
170,895
-0.9%
0.01%
+16.7%
Q3 2019$16,525,000
+0.0%
172,419
-0.1%
0.01%0.0%
Q2 2019$16,518,000
+6.0%
172,619
-2.2%
0.01%0.0%
Q1 2019$15,582,000
+6.8%
176,568
+0.5%
0.01%
-14.3%
Q4 2018$14,590,000
-10.6%
175,614
+1.3%
0.01%
+16.7%
Q3 2018$16,323,000
-13.6%
173,278
+1.1%
0.01%
-25.0%
Q2 2018$18,887,000
+13.6%
171,458
+1.9%
0.01%
+14.3%
Q1 2018$16,633,000
+24.7%
168,267
+2.7%
0.01%
+16.7%
Q4 2017$13,341,000
+11.8%
163,902
+1.0%
0.01%
+20.0%
Q3 2017$11,934,000
+3.2%
162,248
+1.6%
0.01%0.0%
Q2 2017$11,559,000
+20.2%
159,652
+3.4%
0.01%0.0%
Q1 2017$9,616,000
-14.7%
154,347
-0.3%
0.01%
-16.7%
Q4 2016$11,268,000
+19.8%
154,885
-1.5%
0.01%
+20.0%
Q3 2016$9,405,000
-5.1%
157,278
-0.0%
0.01%
-16.7%
Q2 2016$9,910,000
+1.4%
157,306
+0.6%
0.01%0.0%
Q1 2016$9,775,000
+8.6%
156,300
+1.7%
0.01%0.0%
Q4 2015$8,998,000
+9.3%
153,708
+0.6%
0.01%
+20.0%
Q3 2015$8,232,000
-9.4%
152,807
+0.3%
0.01%
-16.7%
Q2 2015$9,088,000
-0.4%
152,412
+0.0%
0.01%0.0%
Q1 2015$9,120,000
-0.4%
152,353
-0.1%
0.01%0.0%
Q4 2014$9,155,000
+24.5%
152,453
+1.1%
0.01%
+20.0%
Q3 2014$7,355,000
-5.5%
150,846
-0.3%
0.01%0.0%
Q2 2014$7,780,000
-7.9%
151,246
+3.5%
0.01%
-16.7%
Q1 2014$8,448,000
+1.5%
146,090
+0.3%
0.01%0.0%
Q4 2013$8,326,000
-5.1%
145,660
-1.3%
0.01%
-25.0%
Q3 2013$8,771,000
+8.6%
147,557
-0.8%
0.01%0.0%
Q2 2013$8,075,000148,7110.01%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
View complete list of UTAH MED PRODS INC shareholders